Last reviewed · How we verify
NCT05128916
Efficacy of Intralesional PRP in Treatment of Onychomycosis
Phase 3 trial testing intralesional platelet rich plasma in Platelet Rich Plasma in 75 participants. Status unknown.
1 June 2022
Quick facts
| Lead sponsor | Sohag University |
|---|---|
| Phase | Phase 3 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 75 |
| Start date | 1 December 2021 |
| Primary completion | 1 June 2022 |
| Estimated completion | 1 September 2022 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- intralesional platelet rich plasma — full drug profile →
- Oral terbinafine
Conditions studied
- Platelet Rich Plasma — all drugs for Platelet Rich Plasma →
Sponsor
Sohag University
Who can join
18 and older, any sex, with Platelet Rich Plasma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate efficacy of intralesional PRP in treatment of finer nail onychomycosis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Efficacy of Intralesional Platelet-Rich Plasma in Treatment of Fingernail Onychomycosis: A Randomized Controlled Trial.
Ali RE, El-Hamd MA, Abdelhamed A, Elsuity MA, et al · · 2026 · PMID 42190181 · DOI 10.5826/dpc.1602a6129
Verify or expand the search:
- PubMed search for NCT05128916
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Platelet Rich Plasma
Currently open trials in the same condition.
- NCT06931457 — Efficacy and Safety of Pulsed Radiofrequency Combined With Platelet Rich Plasma to Treat Idiopathic Glossopharyngeal Neu · recruiting
- NCT06358807 — Microfracture With Platelet Rich Plasma Gel Injection for Osteochondral Lesion of the Talus · NA · recruiting
Other Sohag University trials
Trials by the same sponsor.
- NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
- NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
- NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
- NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
- NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05128916 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sohag University
- Last refreshed: 22 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05128916.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing